Paratek Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Tailwinds Conference 2001

Apr 02, 2001, 01:00 ET from Paratek Pharmaceuticals, Inc.

    BOSTON, April 2 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. announced
 that Thomas J. Bigger, Paratek's President and Chief Executive Officer, is
 scheduled to report on the company's research and development programs at the
 Thomas Weisel Partners Healthcare Tailwinds Conference 2001 -- Specialty
 Pharmaceuticals, Drug Delivery and Healthcare Technology at the Ritz Carlton
 Hotel in San Francisco on Monday, April 2, 2001 beginning at 10:00 a.m. PDT.
     The presentation will be webcast live and available for replay for 30 days
 at: [http://www.veracast.com/twp_healthcare_2001/webcasts/17105358.cfm].
 
     Paratek Pharmaceuticals, Inc. is a privately-held specialty
 pharmaceuticals company headquartered in Boston, MA, that is engaged in the
 discovery and commercialization of new therapeutics that treat
 life-threatening infectious diseases.  In particular, Paratek's mission is to
 overcome the major worldwide problem of bacterial resistance through the
 application of its proprietary technology to the development of new antibiotic
 and anti-infective products.  Paratek was founded in 1996 by Dr. Stuart B.
 Levy, Professor of Molecular Biology and Microbiology and of Medicine at Tufts
 University School of Medicine, and by Dr. Walter Gilbert, the Nobel
 Prize-winning Professor at Harvard University.  During 1999, Paratek entered
 into a $95 million plus royalties deal with Glaxo Wellcome plc
 (now GlaxoSmithKline plc), one of the largest biopartnering deals in the US
 that year.  Paratek's product development programs are expected to yield
 multiple products for the treatment of infectious diseases.
 
     For more information, visit Paratek's website at
 http://www.paratekpharm.com.
 
     Contact:
     Beverly Armstrong                     Raj Punwaney, M.D., M.B.A.
     Paratek Pharmaceuticals, Inc.         Burns McClellan
     (617)-275-0040, x216                  (212)-213-0006
 
 

SOURCE Paratek Pharmaceuticals, Inc.
    BOSTON, April 2 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. announced
 that Thomas J. Bigger, Paratek's President and Chief Executive Officer, is
 scheduled to report on the company's research and development programs at the
 Thomas Weisel Partners Healthcare Tailwinds Conference 2001 -- Specialty
 Pharmaceuticals, Drug Delivery and Healthcare Technology at the Ritz Carlton
 Hotel in San Francisco on Monday, April 2, 2001 beginning at 10:00 a.m. PDT.
     The presentation will be webcast live and available for replay for 30 days
 at: [http://www.veracast.com/twp_healthcare_2001/webcasts/17105358.cfm].
 
     Paratek Pharmaceuticals, Inc. is a privately-held specialty
 pharmaceuticals company headquartered in Boston, MA, that is engaged in the
 discovery and commercialization of new therapeutics that treat
 life-threatening infectious diseases.  In particular, Paratek's mission is to
 overcome the major worldwide problem of bacterial resistance through the
 application of its proprietary technology to the development of new antibiotic
 and anti-infective products.  Paratek was founded in 1996 by Dr. Stuart B.
 Levy, Professor of Molecular Biology and Microbiology and of Medicine at Tufts
 University School of Medicine, and by Dr. Walter Gilbert, the Nobel
 Prize-winning Professor at Harvard University.  During 1999, Paratek entered
 into a $95 million plus royalties deal with Glaxo Wellcome plc
 (now GlaxoSmithKline plc), one of the largest biopartnering deals in the US
 that year.  Paratek's product development programs are expected to yield
 multiple products for the treatment of infectious diseases.
 
     For more information, visit Paratek's website at
 http://www.paratekpharm.com.
 
     Contact:
     Beverly Armstrong                     Raj Punwaney, M.D., M.B.A.
     Paratek Pharmaceuticals, Inc.         Burns McClellan
     (617)-275-0040, x216                  (212)-213-0006
 
 SOURCE  Paratek Pharmaceuticals, Inc.